News
Neonatal care company Neotech Products acquires breastfeeding assistance device
The Bridge device helps babies latch to the breast and helps promote milk production

The California-based neonatal and paediatric care company Neotech Products has acquired the Bridge breastfeeding assistance device.
The device features a silicone nipple cover with a built-in channel, which attaches to a syringe that can hold and deliver breastmilk or formula.
It helps babies latch to the breast and helps promote milk production and it can be used in most circumstances in which a bottle would traditionally be used.
“I created the Bridge because there was a lack of solutions for the most common issues I was seeing in practice,” said Kate Spivak, a physician assistant and the creator behind the breastfeeding device.
“I consistently saw babies who were being supplemented with a bottle due to low supply and issues with latch.
“Theoretically, the solution was simple: keep the baby at the breast as much as possible. Realistically, there was no efficient way to do that until the Bridge was created.”
A large percentage of mothers experience breastfeeding challenges, including difficulty with infant feeding at the breast, pain, and milk quantity.
The developers say the Bridge breastfeeding assistance device provides a surface for baby to latch and allows supplementation while breastfeeding which helps to stimulate natural milk production
It can be used to provide colostrum, expressed milk, fortified human milk or formula and allows control of supplement flow, rate and timing.
Commenting on the acquisition, Craig McCrary, Neotech president, said: “Neotech is primarily known as a NICU company, but the Bridge is a natural progression into the Mother Baby market.
“We have a few other products in the works for the Mother Baby space. The Bridge marks the start of a new era for Neotech.”
Mental health
Women more likely than men to get health advice from influencers, study finds

Young women are more likely than young men to get health and wellness information from social media influencers, a US survey has found.
Among adults aged 18 to 29, 57 per cent of women said they received health and wellness information from influencers, compared with 47 per cent of men.
The Pew Research Center study surveyed 5,023 US adults and examined how young people consume health and wellness content online.
Local university students said influencer content frequently appeared in their social media feeds.
Kabija Koroma, a local university student, said: “It’s more exercise stuff, more like protein and like meals and like how to get ready and like the outfits of the day of videos on TikTok or lately. My favourite ones.”
About 51 per cent of women under 30 said they often consumed influencer content focused on beauty and personal appearance, compared with 18 per cent of men.
The study also found that 21 per cent of women often saw content about therapies outside mainstream medicine, compared with 10 per cent of men.
At least one-third of both young women and young men often encountered influencer content about mental health and weight loss. Around half or more of both groups regularly saw fitness-related content.
Another local university student, Ania Davis, said: “I see a lot like how to meal prep and how to get your morning started. Affirmations stuff. But I do also ask the adults around me because sometimes the internet is not right.”
Researchers also looked at why young adults sought health and wellness information from influencers.
About 51 per cent of young women said they watched the content because they wanted to change their health or lifestyle.
Women were also more likely than men to say they enjoyed hearing from people who shared their background or beliefs, at 23 per cent compared with 14 per cent.
Nineteen per cent of young women said they used influencer content to learn about topics they did not want to ask their doctors about, compared with 10 per cent of young men.
Despite regularly using social media, some students said they did not rely solely on influencer content when making decisions about their health and wellness.
Koroma said: “I’m always on TikTok 24/7 and Instagram, but I also like to ask people older than me because I don’t know everything.”
Menopause
Menopause hormone treatment may ease brain fog, study suggests

Estriol treatment may ease menopause brain fog and other cognitive symptoms, according to a small observational study of 20 menopausal women.
The study involved menopausal women with an average age of 53.
They underwent an initial assessment of their cognitive symptoms before receiving a customised regimen of estriol and progesterone for 12 months.
Estriol is a natural form of oestrogen that occurs during pregnancy and has been used in Europe and Asia to treat menopausal symptoms including hot flushes and genitourinary symptoms.
It differs from estradiol, the most commonly used oestrogen hormone therapy in the US, by binding primarily to a different oestrogen receptor in the brain.
Previous research has shown that estriol may help protect brain cells and reduce brain atrophy in the hippocampus, the region responsible for learning and memory.
After 12 months of treatment, participants reported significant reductions in brain fog, concentration problems, working memory problems, slower processing speed, verbal memory problems and problem-solving difficulties compared with before treatment.
Senior author Dr Rhonda Voskuhl, a neurologist and member of the Comprehensive Menopause Center at UCLA Health, said: “Oestrogen plays a well-documented role in protecting the brain, yet there are still no approved type and dose of treatment that specifically targets the cognitive symptoms so many women experience during menopause.
“Women are often told to simply live with brain fog, when in fact there is a neuroscience basis for it, and potentially a way to address it. That gap in care is what motivated us to look more closely at estriol.”
Researchers also examined estriol treatment in midlife female mice to investigate how the hormone treatment might work.
Estriol reduced markers of brain pathology in the hippocampus and improved measures of working and spatial memory in the animals.
The findings are preliminary. The study was a small case series with no placebo group or randomisation, meaning the results may not apply to broader populations.
The researchers said larger placebo-controlled clinical trials using brain imaging and standardised cognitive testing are needed to confirm the findings on cognitive symptoms.
The treatment used in the study was invented by Voskuhl and is patented by UCLA. UCLA licenses the patent to CleopatraRX, which sells the treatment as PearlPAK. Voskuhl serves as a medical adviser to CleopatraRX.
News
Women shouldering hidden burden of navigating healthcare system – study

Women face a hidden burden navigating healthcare, with many repeatedly retelling their medical history, a national study suggests.
The findings indicate that Canadian women are taking on cognitive, emotional and administrative work alongside managing their health, including coordinating providers and advocating for care.
More than half of women surveyed, 53 per cent, reported a past or current chronic condition, while 64 per cent said there were health topics they struggled to raise with their doctor.
Sarah Hoffman, president and CEO of Pacific Blue Cross, said: “These findings challenge us to think differently about women’s healthcare and highlight the hidden work required to navigate the system.
“For many women, managing their health has also come to mean managing the healthcare system itself.
“They are acting as project managers of their own care, shouldering the invisible labour of coordinating between providers, retelling their medical history and advocating to be heard.
“The gap between men and women is meaningful and raises important questions about why younger women report lower levels of confidence and support.
“It also challenges us to consider whether we are actually making progress in women’s care, and whether the next generation is being equipped with the confidence and voice to advocate for their health.”
Overall, 71 per cent of Canadians described their doctors as supportive and 88 per cent expected their appointments to go well.
Among women living with chronic conditions, 71 per cent reported having to repeat their complete health history multiple times a year.
Younger women were particularly likely to report difficulties discussing their health. The study found 81 per cent of Gen Z women aged 18 to 30 and 73 per cent of Millennial women aged 31 to 45 had health topics they struggled to raise with their doctor.
Among Gen Z women with chronic illness, 92 per cent reported having to repeat their complete health history.
The study also found differences between young women and men. While 95 per cent of Gen Z men expected a doctor’s appointment to go well, the figure was 82 per cent among Gen Z women.
Similarly, 82 per cent of Gen Z men said they felt supported by their family doctor, compared with 66 per cent of Gen Z women.
Reasons for holding back health concerns varied between generations.
Among Gen Z women, 30 per cent cited fear of dismissal and 29 per cent fear of judgement.
Embarrassment was the most common barrier among Millennial, Gen X and Boomer women, reported by 29 per cent, 27 per cent and 35 per cent respectively.
Women who felt they needed to prove themselves to be taken seriously said they adapted how they approached appointments.
Strategies included researching medical information, repeatedly describing or justifying symptoms, bringing written notes or documentation, tracking symptom timelines, making repeat visits and emphasising how symptoms affected their daily lives.
The study also found an association between feeling supported by a doctor and expecting appointments to go well.
Canadians who described their physician as supportive were nearly four times more likely to expect appointments to go well than those who felt unsupported, at 98 per cent compared with 25 per cent.
Overall, 66 per cent of Canadians said they described their symptoms accurately. This fell to 48 per cent among those who said they felt unsupported by their doctor.
The 2026 Blue Cross Women’s Health Study surveyed 2,045 adult Canadians online in March 2026 through independent research company Research + Knowledge = Insights.
The survey had a reported margin of error of plus or minus 2 per cent, 19 times out of 20.
Hormonal health2 weeks agoMajor UK study could be a ‘game-changer’ for heavy periods and endometriosis
Entrepreneur4 days agoKOVE Medical raises €1.7 million to improve safety of foetal surgery
Pregnancy5 days agoUK study aims to transform maternity care for high-risk pregnancies
Events2 weeks agoOne week left to apply: W Accelerate with Merck KGaA and M Ventures
Menopause2 weeks agoQuarter of women miss work due to menstual symptoms, survey finds
Mental health1 week agoPMDD after SSRIs or hormones: Why the brain may be the missing treatment target
Insight2 weeks agoStudy to tackle years-long delays in endometriosis diagnosis
Diagnosis1 week agoArk Surgical secures further institutional backing to accelerate US expansion












1 Comment